Pricy #inhalers remain expensive due to device tweaks that keep competitors at bay
#Drugmakers incremental adjustments to older inhaler products to fend off #generics. Feldman found that just 1 of 62 approved by #FDA 1986-2020 had a new mechanism of action
https…
#inhalers #drugmakers #generics #fda
High profits from secondary patents on #inhalers could decrease incentive for #pharmaceutical companies to innovate @JAMA_current https://jamanetwork.com/journals/jama/fullarticle/2800037
We just saw this on the birdsite from @wbfeldman. Similar observation to ours regarding devices and just published in JAMA. Great that this aspect of patent manipulation is getting attention!
https://twitter.com/wbfeldman/status/1610329075918184451
From 2000-2021, manufacturers earned $111 billion on brand-name #inhalers in the US AFTER patents on their active ingredients had expired.
How?
By patenting other aspects of the products (e.g., delivery devices).
#patents #generics #bigpharma #pharmaceuticals #OrangeBook #inhalers
I JUST got 3 months of #Symbicort and my allergist wants me to try this (naturally). Same thing plus a third med.
Anyone have experience with #Breztri?
#symbicort #breztri #asthma #asthmatic #inhalers